Mexiletine in Sporadic Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Sporadic Amyotrophic Lateral Sclerosis
Interventions
DRUG

Mexiletine

DRUG

Placebo

Trial Locations (10)

10032

Columbia Universtiy Medical Center, New York

15213

University of Pittsburgh, Pittsburgh

17033

Pennsylvania State Hershey Medical Center, Hershey

29425

Medical University of South Carolina, Charleston

30912

Augusta University, Augusta

48109

University of Michigan, Ann Arbor

85013

Barrow Neurological Institute, Phoenix

92868

University of California, Irvine, Orange

98195

University of Washington, Seattle

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

University of Washington

OTHER

NCT02781454 - Mexiletine in Sporadic Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter